Cytiva Videos

  1. Designing ADC Manufacturing For Operator And Patient Safety 11/6/2026

    ADC manufacturing succeeds when manufacturability is treated as an early design input. Cell line choices, toxic payload handling, and single-use extractables each shape operator exposure and risk.

  2. The Body As A Bioreactor – The Execution 10/31/2026

    Genomic medicine depends as much on infrastructure as on the therapies themselves. Distributed production, scalable processes, and evolving regulation shape whether these medicines reach patients.

  3. Managing Risk Across The Single-Use System Lifecycle 9/24/2026

    Single-use system risk extends from initial design through installation and use. See how lifecycle-wide controls can strengthen contamination prevention and support regulatory readiness.

  4. How Can We Help You Achieve Drug Product Risk Control? 9/24/2026

    Learn how you can strengthen contamination control by applying risk-based principles across the single-use system lifecycle, from design and validation through handling and use.

  5. Single-Use Systems And Drug Product Manufacturing Challenges 9/24/2026

    EU GMP Annex 1 calls for contamination control across the full manufacturing process. Learn why filter integrity testing alone is not enough and how evaluating fluid paths can strengthen quality.

  6. New Promises, New Pressures, No Problem - Service Care Packages 8/19/2026

    Tighter production schedules leave little room for equipment disruption. Get support that can strengthen maintenance strategies, reduce operational risk, and help internal teams sustain performance.

  7. The Body As A Bioreactor – Delivering The Vision 8/8/2026

    Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.

  8. The Body As A Bioreactor – The Vision 5/15/2026

    As cell therapy manufacturing reaches its limits, a new model is emerging. Learn how in vivo approaches that harness the body as a bioreactor could expand access and reshape the future.

  9. Why Requalify? 4/14/2026

    Qualification is not a one-and-done activity in regulated environments. Learn when requalification is required and how lifecycle-based testing helps ensure equipment performance and compliance.

  10. Aseptic Filling Strategies With Speed, Precision, And Contamination Control 4/9/2026

    Automated, closed systems are redefining aseptic filling for cell therapies. Eliminate contamination risks and accelerate your path to GMP readiness with flexible, robotic technology.